Related Experiment Videos
Targets for endothelin in the diseased kidney: clues for therapeutic intervention
1Fifth Department of Medicine, University Hospital Mannheim, University of Heidelberg, Germany. rohmeiss@rumms.uni-mannheim.de
Abstract:
The endothelin system has been implicated in various renal diseases. This review focuses on the involvement of endothelin-1 in pathogenesis and pathophysiology of acute and chronic renal failure with regard to its hemodynamic and nonhemodynamic effects. Future developments concerning the use of endothelin receptor antagonists and the role of endothelin in the kidney transplantation setting are discussed.
Insights
The endothelin system, particularly endothelin-1, plays a key role in acute and chronic kidney failure. Understanding its effects may lead to new treatments for renal diseases and improve outcomes after kidney transplantation.
Area of Science:
- Nephrology
- Molecular Medicine
- Cardiovascular Research
Background:
- The endothelin system is increasingly recognized for its significant role in the development and progression of diverse renal diseases.
- Endothelin-1 (ET-1) is a potent vasoconstrictor peptide with critical implications in renal pathophysiology.
Discussion:
- This review examines the multifaceted involvement of ET-1 in the pathogenesis of acute and chronic renal failure.
- It details both the hemodynamic (vasoconstriction, blood pressure regulation) and nonhemodynamic (fibrosis, inflammation, cell proliferation) effects of ET-1 in the kidneys.
Key Insights:
- ET-1 contributes to renal injury through complex mechanisms affecting renal hemodynamics and cellular processes.
- Dysregulation of the endothelin system is a common feature in various kidney diseases, highlighting its therapeutic potential.
Outlook:
- Future research directions include the development and application of endothelin receptor antagonists for treating renal conditions.
- The role of ET-1 in the context of kidney transplantation and its potential impact on graft survival are also explored.